Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
839.00Prev. Close
839.80Volume
8,65,428Total traded value
70.07 CrUpper Circuit
971.60Lower Circuit
647.80Fundamentals
| Market Cap | ₹15,050Cr |
| ROE | 24.79% |
| P/E Ratio(TTM) | 8.88 |
| EPS(TTM) | 94.65 |
| P/B Ratio | 1.98 |
| Dividend Yield | 0.71% |
| Industry P/E | 35.07 |
| Book Value | 424.71 |
| Debt to Equity | 0.04 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Natco Pharma
Natco Pharma is a leading pharmaceutical company that develops and markets finished medicines, their core ingredients (APIs), and intermediates for Indian and international markets. The company is driven by its core mission of making specialty medicines accessible to all, focusing on developing complex and high-potential generic products. In the last financial year, the company achieved its highest-ever revenues, surpassing a significant milestone of over ₹4,000 crores for the first time.;
| Parent Organisation | Natco Pharma Limited |
| Managing Director | Shri. V. Nannapaneni |
| NSE Symbol | NATCOPHARM |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 102.92 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.00 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.72 | ||
| Wockhardt | NA (0.00%) | -151.40 |